Related references
Note: Only part of the references are listed.Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma
Giulio Donati et al.
MOLECULAR ONCOLOGY (2022)
Valine tRNA levels and availability regulate complex I assembly in leukaemia
Palaniraja Thandapani et al.
NATURE (2022)
GCN2 kinase activation by ATP-competitive kinase inhibitors
Colin P. Tang et al.
NATURE CHEMICAL BIOLOGY (2022)
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
Alexander C. Lewis et al.
BLOOD (2022)
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Sumaiyah K. Rehman et al.
CELL (2021)
The Gene Ontology resource: enriching a GOld mine
Seth Carbon et al.
NUCLEIC ACIDS RESEARCH (2021)
Balancing of mitochondrial translation through METTL8-mediated m3C modification of mitochondrial tRNAs
Eva Scholler et al.
MOLECULAR CELL (2021)
A comprehensive phenotypic CRISPR-Cas9 screen of the ubiquitin pathway uncovers roles of ubiquitin ligases in mitosis
Frances V. Hundley et al.
MOLECULAR CELL (2021)
Targeting the Integrated Stress Response in Cancer Therapy
Xiaobing Tian et al.
FRONTIERS IN PHARMACOLOGY (2021)
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
Roberto Vendramin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
Luciano Garofano et al.
NATURE CANCER (2021)
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P. Nusinow et al.
CELL (2020)
Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan et al.
DRUG RESISTANCE UPDATES (2020)
Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade
Cecile Gstalder et al.
CANCER DISCOVERY (2020)
Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma
Martina Messner et al.
FASEB JOURNAL (2020)
A Genetic Map of the Response to DNA Damage in Human Cells
Michele Olivieri et al.
CELL (2020)
Genome-Wide Screens Reveal that Resveratrol Induces Replicative Stress in Human Cells
Yahya Benslimane et al.
MOLECULAR CELL (2020)
Rational discovery of molecular glue degraders via scalable chemical profiling
Cristina Mayor-Ruiz et al.
NATURE CHEMICAL BIOLOGY (2020)
Small-molecule inhibitors of human mitochondrial DNA transcription
Nina A. Bonekamp et al.
NATURE (2020)
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen et al.
CELL (2020)
The integrated stress response: From mechanism to disease
Mauro Costa-Mattioli et al.
SCIENCE (2020)
An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance
Ningning Li et al.
ONCOGENESIS (2019)
Inhibition of mitochondrial translation selectively targets osteosarcoma
Jianguo Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
Alberto Cruz-Bermudez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Multiple cancer pathways regulate telomere protection
Leire Bejarano et al.
EMBO MOLECULAR MEDICINE (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response
David Sharon et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
Jayshree Hirpara et al.
REDOX BIOLOGY (2019)
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism
Ryan J. Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma
Micol Rava et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is
Sida Liao et al.
GENES & DEVELOPMENT (2018)
FBXW7: a critical tumor suppressor of human cancers
Chien-Hung Yeh et al.
MOLECULAR CANCER (2018)
DAPAR & ProStaR: software to perform statistical analyses in quantitative discovery proteomics
Samuel Wieczorek et al.
BIOINFORMATICS (2017)
Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals
Pedro M. Quiros et al.
JOURNAL OF CELL BIOLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
T. S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence
Katherine R. Singleton et al.
CELL REPORTS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee et al.
CELL METABOLISM (2017)
A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors
Sergio Ruiz et al.
MOLECULAR CELL (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Toward a Shared Vision for Cancer Genomic Data
Robert L. Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check
Victor M. Diaz et al.
SEMINARS IN CANCER BIOLOGY (2016)
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
Aleco D'Andrea et al.
ONCOTARGET (2016)
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Luigi Ippolito et al.
ONCOTARGET (2016)
Fbxw7-associated drug resistance is reversed by induction of terminal differentiation in murine intestinal organoid culture
Federica Lorenzi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Improving brightness and photostability of green and red fluorescent proteins for live cell imaging and FRET reporting
Bryce T. Bajar et al.
SCIENTIFIC REPORTS (2016)
Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer
Lekun Fang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata et al.
CANCER DISCOVERY (2015)
FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
Ningning Li et al.
ONCOTARGET (2015)
High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
Gillian Farnie et al.
ONCOTARGET (2015)
The small molecule ISRIB reverses the effects of elF2α phosphorylation on translation and stress granule assembly
Carmela Sidrauski et al.
ELIFE (2015)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
Camilo Guzman et al.
PLOS ONE (2014)
Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy
Rachael M. Ivatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
Francisca Vazquez et al.
CANCER CELL (2013)
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
Alexander Roesch et al.
CANCER CELL (2013)
An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
Amrita Basu et al.
CELL (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Pharmacological brake-release of mRNA translation enhances cognitive memory
Carmela Sidrauski et al.
ELIFE (2013)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Skrtic et al.
CANCER CELL (2011)
A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity
Sergio Ruiz et al.
CURRENT BIOLOGY (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
FBXW7/hCDC4 is a general tumor suppressor in human cancer
Shahab Akhoondi et al.
CANCER RESEARCH (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Antibiotic susceptibility of mammalian mitochondrial translation
L Zhang et al.
FEBS LETTERS (2005)
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
WY Wei et al.
CANCER CELL (2005)
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
F Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
M Yada et al.
EMBO JOURNAL (2004)
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase
DM Koepp et al.
SCIENCE (2001)
Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor
N Gupta-Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
